Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
暂无分享,去创建一个
M. Rizzetto | R. Pellicano | G. Saracco | G. P. Caviglia | A. Ciancio | C. Rosso | M. Abate | A. Olivero | A. Smedile | S. Gaia | E. Petrini | C. Bosco